Globus Medical (GMED) Stock Forecast & Price Target

Compare

874 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GMED Analyst Ratings

Moderate Buy

9 Buy

7 Hold

0 Sell

Based on 16 analysts giving stock ratings to

Globus

Medical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GMED Stock 12 Month Forecast

Average Price Target

$82.33

▲(53.49% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is $82.33 with a high forecast of $105.00 and a low forecast of $57.00. The average price target represents a 53.49% change from the last price of $53.64.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"56":"$56","81":"$81","106":"$106","68.5":"$68.5","93.5":"$93.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$105.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":82.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$82.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":57,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$57.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[56,68.5,81,93.5,106],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.2,63.64615384615385,67.0923076923077,70.53846153846155,73.98461538461538,77.43076923076923,80.87692307692308,84.32307692307693,87.76923076923077,91.21538461538461,94.66153846153847,98.1076923076923,101.55384615384615,{"y":105,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.2,61.902307692307694,63.604615384615386,65.30692307692308,67.00923076923077,68.71153846153847,70.41384615384615,72.11615384615385,73.81846153846153,75.52076923076923,77.22307692307692,78.92538461538462,80.62769230769231,{"y":82.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.2,59.95384615384616,59.70769230769231,59.46153846153847,59.215384615384615,58.96923076923077,58.723076923076924,58.47692307692308,58.23076923076923,57.98461538461539,57.738461538461536,57.49230769230769,57.246153846153845,{"y":57,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":67.92,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.1,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.7,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.4,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.88,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.9,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.71,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.72,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.32,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.39,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.11,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.96,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$105.00

Average Price Target$82.33

Lowest Price Target$57.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$57

Hold

6.26%

Upside

Downgraded

07/22/25

Globus Medical shows strong financial health and promising strategic initiatives like new leadership and a share buyback program, which are positive signals. However, technical indicators suggest current negative momentum, and valuation metrics indicate potential overvaluation. Future growth opportunities from acquisitions and product launches are balanced by current operational challenges.

Richard NewitterTruist Financial

Truist Financial

―

Hold

―

Reiterated

07/22/25

Globus Medical (GMED) Gets a Hold from Truist Financial

Matthew TaylorJefferies

Jefferies

$90→$88

Buy

64.06%

Upside

Reiterated

07/22/25

Globus Medical price target lowered to $88 from $90 at JefferiesGlobus Medical price target lowered to $88 from $90 at Jefferies

Caitlin CroninCanaccord Genuity

Canaccord Genuity

$97→$90

Buy

67.79%

Upside

Reiterated

07/22/25

Globus Medical price target lowered to $90 from $97 at CanaccordGlobus Medical price target lowered to $90 from $97 at Canaccord

Jason WittesRoth MKM

Roth MKM

$105

Buy

95.75%

Upside

Reiterated

07/21/25

Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR) and Globus Medical (NYSE: GMED)

Kallum TitchmarshMorgan Stanley

Morgan Stanley

$68

Buy

26.77%

Upside

Reiterated

07/21/25

Optimistic Outlook on Globus Medical: Strategic Changes and Positive Q2 Performance Drive Buy RatingWe did have a few clients that, following a more confident tone by management, were anticipating a slightly larger topline beat (including after J&J continued to point to competitive pressures in Spine). Equally, the beat being driven by NVRO may be a little disappointing for some, raising questions on the base business. The stock price tells the story though, having had little recovery since the Q1 challenges and really showing the anxiety in the market, suggesting overall expectations were pretty low.

David SaxonNeedham

Needham

―

Hold

―

Reiterated

07/21/25

Hold Rating Maintained for Globus Medical Amid CEO Transition and Growth ConcernsWe intend to wait to update our model until GMED reports full 2Q25 results, expected on 8/7.

Shagun Singh ChadhaRBC Capital

RBC Capital

$95

Buy

77.11%

Upside

Reiterated

07/21/25

RBC Capital Sticks to Their Buy Rating for Globus Medical (GMED)

Ryan ZimmermanBTIG

BTIG

―

Hold

―

Reiterated

07/21/25

Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns

Matthew O'BrienPiper Sandler

Piper Sandler

$80

Buy

49.14%

Upside

Reiterated

07/03/25

Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)

Matt MiksicBarclays

Barclays

$103

Buy

92.02%

Upside

Reiterated

06/18/25

Globus Medical (GMED) Receives a Buy from Barclays

David TurkalyCitizens JMP

Citizens JMP

―

Hold

―

Reiterated

05/27/25

Citizens JMP Remains a Hold on Globus Medical (GMED)

Steven LichtmanOppenheimer

Oppenheimer

$90→$78

Hold

45.41%

Upside

Reiterated

05/09/25

Globus Medical (GMED) PT Lowered to $78 at OppenheimerOppenheimer analyst Steven Lichtman lowered the price target on Globus Medical (NYSE: GMED) to $78.00 (from $90.00) while maintaining a Perform rating.

Mathew BlackmanStifel Nicolaus

Stifel Nicolaus

$94→$70

Buy

30.50%

Upside

Reiterated

05/09/25

Globus Medical (GMED) PT Lowered to $70 at StifelStifel analyst Mathew Blackman lowered the price target on Globus Medical (NYSE: GMED) to $70.00 (from $94.00) while maintaining a Buy rating.

Craig BijouBank of America Securities

Bank of America Securities

$97→$78

Hold

45.41%

Upside

Reiterated

05/09/25

Globus Medical Faces Challenges: Hold Rating Amid Revenue Miss and Cautious OutlookWe reiterate Neutral as investors likely need to see a couple of quarters of solid execution to come back to the story. We lower our PO to $78 (from $97).

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$57

Hold

6.26%

Upside

Downgraded

07/22/25

Richard NewitterTruist Financial

Truist Financial

―

Hold

―

Reiterated

07/22/25

Globus Medical (GMED) Gets a Hold from Truist Financial

Matthew TaylorJefferies

Jefferies

$90→$88

Buy

64.06%

Upside

Reiterated

07/22/25

Globus Medical price target lowered to $88 from $90 at JefferiesGlobus Medical price target lowered to $88 from $90 at Jefferies

Caitlin CroninCanaccord Genuity

Canaccord Genuity

$97→$90

Buy

67.79%

Upside

Reiterated

07/22/25

Globus Medical price target lowered to $90 from $97 at CanaccordGlobus Medical price target lowered to $90 from $97 at Canaccord

Jason WittesRoth MKM

Roth MKM

$105

Buy

95.75%

Upside

Reiterated

07/21/25

Analysts Offer Insights on Healthcare Companies: Danaher (NYSE: DHR) and Globus Medical (NYSE: GMED)

Kallum TitchmarshMorgan Stanley

Morgan Stanley

$68

Buy

26.77%

Upside

Reiterated

07/21/25

David SaxonNeedham

Needham

―

Hold

―

Reiterated

07/21/25

Hold Rating Maintained for Globus Medical Amid CEO Transition and Growth ConcernsWe intend to wait to update our model until GMED reports full 2Q25 results, expected on 8/7.

Shagun Singh ChadhaRBC Capital

RBC Capital

$95

Buy

77.11%

Upside

Reiterated

07/21/25

RBC Capital Sticks to Their Buy Rating for Globus Medical (GMED)

Ryan ZimmermanBTIG

BTIG

―

Hold

―

Reiterated

07/21/25

Hold Rating on Globus Medical Amid Management Changes and Spine Business Concerns

Matthew O'BrienPiper Sandler

Piper Sandler

$80

Buy

49.14%

Upside

Reiterated

07/03/25

Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)

Matt MiksicBarclays

Barclays

$103

Buy

92.02%

Upside

Reiterated

06/18/25

Globus Medical (GMED) Receives a Buy from Barclays

David TurkalyCitizens JMP

Citizens JMP

―

Hold

―

Reiterated

05/27/25

Citizens JMP Remains a Hold on Globus Medical (GMED)

Steven LichtmanOppenheimer

Oppenheimer

$90→$78

Hold

45.41%

Upside

Reiterated

05/09/25

Mathew BlackmanStifel Nicolaus

Stifel Nicolaus

$94→$70

Buy

30.50%

Upside

Reiterated

05/09/25

Globus Medical (GMED) PT Lowered to $70 at StifelStifel analyst Mathew Blackman lowered the price target on Globus Medical (NYSE: GMED) to $70.00 (from $94.00) while maintaining a Buy rating.

Craig BijouBank of America Securities

Bank of America Securities

$97→$78

Hold

45.41%

Upside

Reiterated

05/09/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

1 Month

xxx

Success Rate

13/22 ratings generated profit

Average Return

+1.69%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +1.69% per trade.

3 Months

xxx

Success Rate

13/22 ratings generated profit

Average Return

+1.60%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +1.60% per trade.

1 Year

Matt MiksicBarclays

Success Rate

20/33 ratings generated profit

Average Return

+9.95%

reiterated a buy rating 2 months ago

Copying Matt Miksic's trades and holding each position for 1 Year would result in 60.61% of your transactions generating a profit, with an average return of +9.95% per trade.

2 Years

xxx

Success Rate

24/33 ratings generated profit

Average Return

+17.21%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 72.73% of your transactions generating a profit, with an average return of +17.21% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMED Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GMED has received 22 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 82.33.

Each month's total comprises the sum of three months' worth of ratings.

GMED Financial Forecast

GMED Earnings Forecast

Next quarter’s earnings estimate for GMED is $0.80 with a range of $0.76 to $0.86. The previous quarter’s EPS was $0.86. GMED beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year GMED has Preformed in-line its overall industry.

GMED Sales Forecast

Next quarter’s sales forecast for GMED is $733.82M with a range of $723.50M to $746.00M. The previous quarter’s sales results were $745.30M. GMED beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year GMED has Preformed in-line its overall industry.

GMED Stock Forecast FAQ

What is GMED’s average 12-month price target, according to analysts?

Based on analyst ratings, Globus Medical’s 12-month average price target is 82.33.

What is GMED’s upside potential, based on the analysts’ average price target?

Globus Medical has 53.49% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GMED a Buy, Sell or Hold?

Globus Medical has a consensus rating of Moderate Buy which is based on 9 buy ratings, 7 hold ratings and 0 sell ratings.

What is Globus Medical’s price target?

The average price target for Globus Medical is 82.33. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $105.00 ,the lowest forecast is $57.00. The average price target represents 53.49% Increase from the current price of $53.64.

What do analysts say about Globus Medical?

Globus Medical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of GMED?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Globus Medical (GMED) Stock Forecast & Price Target

GMED Analyst Ratings

GMED Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Globus Medical

GMED Analyst Recommendation Trends

GMED Financial Forecast

GMED Earnings Forecast

GMED Sales Forecast

GMED Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts